Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Proteomics|August 12, 2011
Pluripotent stem cell heterogeneity and the evolving role of proteomic technologies in stem cell biologyRebekah L Gundry, Paul W Burridge, Kenneth R Boheler
Molecular Biotechnology|May 17, 2017
Transient Activation of Reprogramming Transcription Factors Using Protein Transduction Facilitates Conversion of Human Fibroblasts Toward Cardiomyocyte-Like CellsZaniar Ghazizadeh, Hassan Rassouli, Hananeh Fonoudi, et al.
Annual Review of Pharmacology and Toxicology|October 3, 2023
Anthracycline Toxicity: Light at the End of the Tunnel?Romina B Cejas, Kateryna Petrykey, Yadav Sapkota, et al.
Molecular Pharmacology|September 17, 2020
GS-967 and Eleclazine Block Sodium Channels in Human Induced Pluripotent Stem Cell-Derived CardiomyocytesFranck Potet, Defne E Egecioglu, Paul W Burridge, et al.
Stem Cells (Dayton, Ohio)|November 25, 2005
Hematopoiesis from human embryonic stem cells: overcoming the immune barrier in stem cell therapiesHelen Priddle, D Rhodri E Jones, Paul W Burridge, et al.
Cell Stem Cell|January 10, 2012
Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogrammingPaul W Burridge, Gordon Keller, Joseph D Gold, et al.
Scientific Reports|March 27, 2024
Nilotinib-induced alterations in endothelial cell function recapitulate clinical vascular phenotypes independent of ABL1Emily A Pinheiro, Jean-Marc DeKeyser, Brian Lenny, et al.
Annual Review of Pharmacology and Toxicology|October 10, 2017
Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and ProblemsTarek Magdy, Adam J T Schuldt, Joseph C Wu, et al.
Journal of Visualized Experiments : Jove|April 14, 2015
Derivation of highly purified cardiomyocytes from human induced pluripotent stem cells using small molecule-modulated differentiation and subsequent glucose starvationArun Sharma, Guang Li, Kuppusamy Rajarajan, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 19, 2015
Modeling Cardiovascular Diseases with Patient-Specific Human Pluripotent Stem Cell-Derived CardiomyocytesPaul W Burridge, Sebastian Diecke, Elena Matsa, et al.
Pageof 10